El Futuro en el Tratamiento del Cáncer Renal - page 33

Lutetium
177
–Labeled Anti–Carbonic Anhydrase IX
Monoclonal Antibody Girentuximab in Patients with mRCC
Muselaers CHJ, et al. Eur Urol 2016
Stillebroer AB, et al. Eur Urol 2013
RCC Tumor
Cell
1...,23,24,25,26,27,28,29,30,31,32 34,35,36
Powered by FlippingBook